Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Chronological changes in renal vascular reactivity in portal hypertensive rats.

Chuang CL, Huang HC, Chang CC, Lee FY, Wu JC, Lee SD.

Eur J Clin Invest. 2013 Mar;43(3):267-76. doi: 10.1111/eci.12040. Epub 2013 Jan 7.

PMID:
23293840
2.

Lipopolysaccharide enhanced renal vascular response to endothelin-1 through ETA overexpression in portal hypertensive rats.

Chuang CL, Huang HC, Chang CC, Lee FY, Wu JC, Lee JY, Hsieh HG, Lee SD.

J Gastroenterol Hepatol. 2015 Jan;30(1):199-207. doi: 10.1111/jgh.12670.

PMID:
24989426
3.

Effects of simvastatin on the portal-systemic collateral vascular response to endothelin-1 and shunting degree in portal hypertensive rats.

Hsu SJ, Wang SS, Hsin IF, Huang HC, Lee FY, Lee JY, Lin HC, Chuang CL, Lee SD.

Scand J Gastroenterol. 2013 Jul;48(7):831-8. doi: 10.3109/00365521.2012.711851. Epub 2013 May 14.

PMID:
23672611
4.

Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats.

Heinemann A, Wachter CH, Holzer P, Fickert P, Stauber RE.

Br J Pharmacol. 1997 Jul;121(5):1031-7.

5.

Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats.

Tsai MH, Iwakiri Y, Cadelina G, Sessa WC, Groszmann RJ.

Gastroenterology. 2003 Nov;125(5):1452-61.

PMID:
14598261
6.

Simvastatin effects on portal-systemic collaterals of portal hypertensive rats.

Huang HC, Wang SS, Lee JY, Chen YC, Lee FY, Lin HC, Chang CC, Lee SD.

J Gastroenterol Hepatol. 2010 Aug;25(8):1401-9. doi: 10.1111/j.1440-1746.2009.06159.x.

PMID:
20659230
7.

Pravastatin administration does not induce detrimental effects on hemodynamics and collaterals of portal hypertensive rats.

Chang CC, Wang SS, Huang HC, Lee JY, Lee FY, Lin HC, Lee SD.

J Gastroenterol Hepatol. 2010 Aug;25(8):1394-400. doi: 10.1111/j.1440-1746.2009.06170.x.

PMID:
20659229
8.

Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.

Niederberger M, Ginés P, Martin PY, Tsai P, Morris K, McMurtry I, Schrier RW.

Hepatology. 1996 Oct;24(4):947-51.

PMID:
8855203
9.
10.

Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.

Moleda L, Trebicka J, Dietrich P, Gäbele E, Hellerbrand C, Straub RH, Sauerbruch T, Schoelmerich J, Wiest R.

Gut. 2011 Aug;60(8):1122-32. doi: 10.1136/gut.2010.226407. Epub 2011 Feb 12.

PMID:
21317421
11.

Role of nitric oxide and endothelin-1 in a portal hypertensive rat model.

Tsugawa K, Hashizume M, Migou S, Kishihara F, Kawanaka H, Tomikawa M, Tanoue K, Sugimachi K.

Scand J Gastroenterol. 2000 Oct;35(10):1097-105.

PMID:
11099065
12.

Vascular hyporesponsiveness in the mesenteric artery of anaesthetized rats with cirrhosis and portal hypertension: an in-vivo study.

Colle IO, De Vriese AS, Van Vlierberghe HR, Lameire NH, De Vos MM.

Eur J Gastroenterol Hepatol. 2004 Feb;16(2):139-45.

PMID:
15075986
13.

Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats.

Reiberger T, Angermayr B, Schwabl P, Rohr-Udilova N, Mitterhauser M, Gangl A, Peck-Radosavljevic M.

J Hepatol. 2009 Nov;51(5):865-73. doi: 10.1016/j.jhep.2009.06.024. Epub 2009 Aug 4.

PMID:
19726100
14.

Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin.

Chu CJ, Wu SL, Lee FY, Wang SS, Chang FY, Lin HC, Chan CC, Lee SD.

Clin Sci (Lond). 2000 Dec;99(6):475-82.

PMID:
11099389
15.

Adrenal dysfunction in portal hypertensive rats with acute hemorrhage.

Lee FY, Wang SS, Tsai MH, Huang HC, Lin HC, Lee SD.

PLoS One. 2014 Mar 14;9(3):e92093. doi: 10.1371/journal.pone.0092093. eCollection 2014.

16.

Renal response to methoxamine in portal hypertensive rats: role of prostaglandins and nitric oxide.

García-Estañ J, Atucha NM, Groszmann RJ.

J Hepatol. 1996 Aug;25(2):206-11.

PMID:
8878783
17.

Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension.

Shah V, Wiest R, Garcia-Cardena G, Cadelina G, Groszmann RJ, Sessa WC.

Am J Physiol. 1999 Aug;277(2 Pt 1):G463-8.

18.

Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.

Xu J, Cao H, Liu H, Wu ZY.

Hepatobiliary Pancreat Dis Int. 2008 Oct;7(5):503-8.

20.

Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.

Theodorakis NG, Wang YN, Korshunov VA, Maluccio MA, Skill NJ.

World J Gastroenterol. 2015 Apr 14;21(14):4126-35. doi: 10.3748/wjg.v21.i14.4126.

Items per page

Supplemental Content

Write to the Help Desk